Literature DB >> 27582337

Suppressive Effect of Kampo Formula "Juzen-taiho-to" on Carbon Tetrachloride-Induced Hepatotoxicity in Mice.

Hiroki Yoshioka1, Shiori Fukaya, Nobuhiko Miura, Satomi Onosaka, Tsunemasa Nonogaki, Akito Nagatsu.   

Abstract

The aim of the present study was to investigate whether pretreatment with the Japanese herbal medicine, "Juzen-taiho-to" (JTX), had an ameliorative effect on carbon tetrachloride (CCl4)-induced hepatotoxicity through anorexia prevention. Mice injected with CCl4 exhibited severe anorexia. Moreover, CCl4 increased the plasma levels of hepatic injury markers (i.e., alanine aminotransferase and aspartate aminotransferase), lipid peroxidation, and hepatic Ca(2+) levels. Pretreatment with JTX recovered the CCl4-induced anorexia. In addition, JTX pretreatment decreased CCl4-induced plasma levels of hepatic injury markers. Increased Ca(2+) is a known indicator of the final progression to hepatocyte death, and CCl4-induced hepatotoxicity is mainly caused by oxidative stress. The present study indicated CCl4-induced lipid peroxidation and hepatic Ca(2+) content decreased with JTX pretreatment. Our results suggest that JTX has potential to protect of CCl4-induced anorexia, and the modulation of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27582337     DOI: 10.1248/bpb.b16-00421

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Sipjeondaebo-tang in patients with breast cancer with fatigue: a protocol for a pilot, randomised, double-blind, placebo-controlled, cross-over trial.

Authors:  Chunhoo Cheon; Sohyeon Kang; Youme Ko; Mia Kim; Bo-Hyoung Jang; Yong-Cheol Shin; Seong-Gyu Ko
Journal:  BMJ Open       Date:  2018-07-06       Impact factor: 2.692

2.  Sipjeondaebo-tang Alleviates Oxidative Stress-Mediated Liver Injury through Activation of the CaMKK2-AMPK Signaling Pathway.

Authors:  Sang Mi Park; Sung Woo Kim; Eun Hye Jung; Hae Li Ko; Chae Kwang Im; Jong Rok Lee; Sung Hui Byun; Sae Kwang Ku; Sang Chan Kim; Chung A Park; Kwang Joong Kim; Il Je Cho
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-06       Impact factor: 2.629

3.  Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice.

Authors:  Takahiro Iwasawa; Shunsuke Nojiri; Atsunori Tsuchiya; Suguru Takeuchi; Takayuki Watanabe; Masahiro Ogawa; Satoko Motegi; Takeki Sato; Masaru Kumagai; Taiki Nakaya; Katsuya Ohbuchi; Miwa Nahata; Naoki Fujitsuka; Masaaki Takamura; Shuji Terai
Journal:  Regen Ther       Date:  2021-07-29       Impact factor: 3.419

4.  Possible anti-oxidative effects of long-term administration of Juzen-taiho-to in dogs.

Authors:  Yuta Shinohara; Ayaka Oyama; Tatsuya Usui; Kazuaki Sasaki
Journal:  J Vet Med Sci       Date:  2019-10-04       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.